{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:27:41Z","timestamp":1789676861107,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.coviro.2013.03.003","type":"journal-article","created":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T04:30:15Z","timestamp":1364963415000},"page":"233-237","source":"Crossref","is-referenced-by-count":58,"title":["Nonhuman primate models for Epstein-Barr virus infection"],"prefix":"10.1016","volume":"3","author":[{"given":"Fred","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2013.03.003_bib0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/JVI.01512-10","article-title":"A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas","volume":"85","author":"Ma","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2013.03.003_bib0010","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1084\/jem.145.4.948","article-title":"Lymphoma in cotton-top marmosets after inoculation with Epstein-Barr virus: tumor incidence, histologic spectrum antibody responses, demonstration of viral DNA, and characterization of viruses","volume":"145","author":"Miller","year":"1977","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2013.03.003_bib0015","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/318287a0","article-title":"Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine","volume":"318","author":"Epstein","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2013.03.003_bib0020","first-page":"59","article-title":"Fatal lymphoproliferative disease associated with a novel gammaherpesvirus in a captive population of common marmosets","volume":"50","author":"Ramer","year":"2000","journal-title":"Comp Med"},{"key":"10.1016\/j.coviro.2013.03.003_sbref0025","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1073\/pnas.98.3.1224","article-title":"An Epstein-Barr-related herpesvirus from marmoset lymphomas","volume":"98","author":"Cho","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2013.03.003_sbref0030","doi-asserted-by":"crossref","first-page":"12055","DOI":"10.1128\/JVI.76.23.12055-12068.2002","article-title":"Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses","volume":"76","author":"Rivailler","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2013.03.003_bib0035","doi-asserted-by":"crossref","first-page":"10069","DOI":"10.1128\/JVI.79.15.10069-10072.2005","article-title":"Reduced prevalence of Epstein-Barr virus-related lymphocryptovirus infection in sera from a new world primate","volume":"79","author":"Fogg","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2013.03.003_bib0040","doi-asserted-by":"crossref","first-page":"10695","DOI":"10.1128\/JVI.77.19.10695-10699.2003","article-title":"Novel simian homologues of Epstein-Barr virus","volume":"77","author":"Ehlers","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2013.03.003_bib0045","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ijc.2910380319","article-title":"Epstein-Barr virus-related herpesvirus from a rhesus monkey (Macaca mulatta) with malignant lymphoma","volume":"38","author":"Rangan","year":"1986","journal-title":"Int J Cancer"},{"key":"10.1016\/j.coviro.2013.03.003_sbref0050","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1128\/JVI.76.1.421-426.2002","article-title":"Complete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model","volume":"76","author":"Rivailler","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2013.03.003_bib0055","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.1128\/JVI.70.11.7819-7826.1996","article-title":"Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1","volume":"70","author":"Franken","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2013.03.003_bib0060","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.1128\/JVI.69.12.8011-8019.1995","article-title":"5\u2032 coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio","volume":"69","author":"Franken","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2013.03.003_bib0065","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/JVI.74.1.379-389.2000","article-title":"Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses","volume":"74","author":"Peng","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2013.03.003_bib0070","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1128\/JVI.73.9.7381-7389.1999","article-title":"Inhibition of antigen presentation by the glycine\/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1","volume":"73","author":"Blake","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2013.03.003_sbref0075","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1128\/JVI.72.4.3205-3212.1998","article-title":"Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virus","volume":"72","author":"Moghaddam","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2013.03.003_bib0080","series-title":"The Laboratory Primate","first-page":"230","article-title":"Development of specific pathogen free non-human primate colonies","author":"Mansfield","year":"2005"},{"key":"10.1016\/j.coviro.2013.03.003_sbref0085","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1126\/science.276.5321.2030","article-title":"An animal model for acute and persistent Epstein-Barr virus infection","volume":"276","author":"Moghaddam","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.coviro.2013.03.003_sbref0090","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1182\/blood-2004-01-0342","article-title":"Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host","volume":"104","author":"Rivailler","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2013.03.003_sbref0095","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1128\/JVI.01411-10","article-title":"Cloning of the Epstein-Barr virus-related rhesus lymphocryptovirus as a bacterial artificial chromosome: a loss-of-function mutation of the rhBARF1 immune evasion gene","volume":"85","author":"Ohashi","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2013.03.003_sbref0100","doi-asserted-by":"crossref","first-page":"e1003095","DOI":"10.1371\/journal.ppat.1003095","article-title":"An Epstein-Barr virus encoded inhibitor of colony stimulating factor-1 signaling is an important determinant for acute and persistent EBV infection","volume":"8","author":"Ohashi","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2013.03.003_bib0105","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","article-title":"Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults","volume":"196","author":"Sokal","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2013.03.003_bib0110","doi-asserted-by":"crossref","first-page":"e1002308","DOI":"10.1371\/journal.ppat.1002308","article-title":"Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challenge","volume":"7","author":"Sashihara","year":"2011","journal-title":"PLoS Pathog"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625713000278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625713000278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T15:08:15Z","timestamp":1595603295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625713000278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1879625713000278"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2013.03.003","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}